Skip to main content

Advertisement

SpringerLink
Log in

Evidence for a Dysregulated Immune System in the Etiology of Psychiatric Disorders

  • INVITED REVIEW
  • Published:
Journal of Neuroimmune Pharmacology Aims and scope Submit manuscript

Abstract

There is extensive bi-directional communication between the brain and the immune system in both health and disease. In recent years, the role of an altered immune system in the etiology of major psychiatric disorders has become more apparent. Studies have demonstrated that some patients with major psychiatric disorders exhibit characteristic signs of immune dysregulation and that this may be a common pathophysiological mechanism that underlies the development and progression of these disorders. Furthermore, many psychiatric disorders are also often accompanied by chronic medical conditions related to immune dysfunction such as autoimmune diseases, diabetes and atherosclerosis. One of the major psychiatric disorders that has been associated with an altered immune system is schizophrenia, with approximately one third of patients with this disorder showing immunological abnormalities such as an altered cytokine profile in serum and cerebrospinal fluid. An altered cytokine profile is also found in a proportion of patients with major depressive disorder and is thought to be potentially related to the pathophysiology of this disorder. Emerging evidence suggests that altered immune parameters may also be implicated in the neurobiological etiology of autism spectrum disorders. Further support for a role of immune dysregulation in the pathophysiology of these psychiatric disorders comes from studies showing the immunomodulating effects of antipsychotics and antidepressants, and the mood altering effects of anti-inflammatory therapies. This review will not attempt to discuss all of the psychiatric disorders that have been associated with an augmented immune system, but will instead focus on several key disorders where dysregulation of this system has been implicated in their pathophysiology including depression, schizophrenia and autism spectrum disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • Abazyan B, Nomura J, Kannan G, Ishizuka K, Tamashiro KL, Nucifora F, Pogorelov V, Ladenheim B, Yang C, Krasnova IN, Cadet JL, Pardo C, Mori S, Kamiya A, Vogel MW, Sawa A, Ross CA, Pletnikov MV (2010) Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology. Biol Psychiatry 68:1172–1181

    Article  CAS  PubMed  Google Scholar 

  • Abbasi SH, Hosseini F, Modabbernia A, Ashrafi M, Akhondzadeh S (2012) Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study. J Affect Disord 141:308–314

    Article  CAS  PubMed  Google Scholar 

  • Abdallah MW, Larsen N, Grove J, Norgaard-Pedersen B, Thorsen P, Mortensen EL, Hougaard DM (2012) Amniotic fluid chemokines and autism spectrum disorders: an exploratory study utilizing a Danish Historic Birth Cohort. Brain Behav Immun 26:170–176

    Article  CAS  PubMed  Google Scholar 

  • Akhondzadeh S, Jafari S, Raisi F, Nasehi AA, Ghoreishi A, Salehi B, Mohebbi-Rasa S, Raznahan M, Kamalipour A (2009) Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Depress Anxiety 26:607–611

    Article  CAS  PubMed  Google Scholar 

  • Alavi M, Grebely J, Matthews GV, Petoumenos K, Yeung B, Day C, Lloyd AR, Van Beek I, Kaldor JM, Hellard M, Dore GJ, Haber PS (2012) Effect of pegylated interferon-alpha-2a treatment on mental health during recent hepatitis C virus infection. J Gastroenterol Hepatol 27:957–965

    Article  CAS  PubMed  Google Scholar 

  • Anderson G, Berk M, Dodd S, Bechter K, Altamura AC, Dell’osso B, Kanba S, Monji A, Fatemi SH, Buckley P, Debnath M, Das UN, Meyer U, Muller N, Kanchanatawan B, Maes M (2013) Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia. Prog Neuro-psychopharmacol Biol Psychiatry 42:1–4

    Google Scholar 

  • Andre C, O’Connor JC, Kelley KW, Lestage J, Dantzer R, Castanon N (2008) Spatio-temporal differences in the profile of murine brain expression of proinflammatory cytokines and indoleamine 2,3-dioxygenase in response to peripheral lipopolysaccharide administration. J Neuroimmunol 200:90–99

    Article  CAS  PubMed  Google Scholar 

  • Anisman H, Merali Z, Poulter MO, Hayley S (2005) Cytokines as a precipitant of depressive illness: animal and human studies. Curr Pharm Des 11:963–972

    Article  CAS  PubMed  Google Scholar 

  • Anisman H, Gibb J, Hayley S (2008) Influence of continuous infusion of interleukin-1beta on depression-related processes in mice: corticosterone, circulating cytokines, brain monoamines, and cytokine mRNA expression. Psychopharmacology 199:231–244

    Article  CAS  PubMed  Google Scholar 

  • Arakawa S, Shirayama Y, Fujita Y, Ishima T, Horio M, Muneoka K, Iyo M, Hashimoto K (2012) Minocycline produced antidepressant-like effects on the learned helplessness rats with alterations in levels of monoamine in the amygdala and no changes in BDNF levels in the hippocampus at baseline. Pharmacol Biochem Behav 100:601–606

    Article  CAS  PubMed  Google Scholar 

  • Arrode-Bruses G, Bruses JL (2012) Maternal immune activation by poly(I:C) induces expression of cytokines IL-1beta and IL-13, chemokine MCP-1 and colony stimulating factor VEGF in fetal mouse brain. J Neuroinflammation 9:83

    Article  CAS  PubMed  Google Scholar 

  • Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van de Water J (2011a) Altered T cell responses in children with autism. Brain Behav Immun 25:840–849

    Article  CAS  PubMed  Google Scholar 

  • Ashwood P, Corbett BA, Kantor A, Schulman H, Van de Water J, Amaral DG (2011b) In search of cellular immunophenotypes in the blood of children with autism. PLoS One 6:e19299

    Article  CAS  PubMed  Google Scholar 

  • Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J (2011c) Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 25:40–45

    Article  CAS  PubMed  Google Scholar 

  • Atladottir HO, Thorsen P, Ostergaard L, Schendel DE, Lemcke S, Abdallah M, Parner ET (2010) Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord 40:1423–1430

    Article  PubMed  Google Scholar 

  • Atzeni F et al (2012) Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and Infliximab in the GISEA registry. Autoimmun Rev 12:225–229

    Article  CAS  PubMed  Google Scholar 

  • Bah TM, Benderdour M, Kaloustian S, Karam R, Rousseau G, Godbout R (2011) Escitalopram reduces circulating pro-inflammatory cytokines and improves depressive behavior without affecting sleep in a rat model of post-cardiac infarct depression. Behav Brain Res 225:243–251

    Article  CAS  PubMed  Google Scholar 

  • Baker I, Masserano J, Wyatt RJ (1996) Serum cytokine concentrations in patients with schizophrenia. Schizophr Res 20:199–203

    Article  CAS  PubMed  Google Scholar 

  • Bale JF Jr (2009) Fetal infections and brain development. Clin Perinatol 36:639–653

    Article  PubMed  Google Scholar 

  • Barr CE, Mednick SA, Munk-Jorgensen P (1990) Exposure to influenza epidemics during gestation and adult schizophrenia. A 40-year study. Arch Gen Psychiatry 47:869–874

    Article  CAS  PubMed  Google Scholar 

  • Barrientos RM, Frank MG, Hein AM, Higgins EA, Watkins LR, Rudy JW, Maier SF (2009) Time course of hippocampal IL-1 beta and memory consolidation impairments in aging rats following peripheral infection. Brain Behav Immun 23:46–54

    Article  CAS  PubMed  Google Scholar 

  • Barrientos RM, Hein AM, Frank MG, Watkins LR, Maier SF (2012) Intracisternal interleukin-1 receptor antagonist prevents postoperative cognitive decline and neuroinflammatory response in aged rats. J Neurosci: Off J Soc Neurosci 32:14641–14648

    Article  CAS  Google Scholar 

  • Benavides J, Toulmond S (1993) Role of cytokines in the central nervous system. Therapie 48:575–584

    CAS  PubMed  Google Scholar 

  • Beumer W, Drexhage RC, De Wit H, Versnel MA, Drexhage HA, Cohen D (2012a) Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome. Psychoneuroendocrinology 37(12):1901–1911

    Google Scholar 

  • Beumer W, Gibney SM, Drexhage RC, Pont-Lezica L, Doorduin J, Klein HC, Steiner J, Connor TJ, Harkin A, Versnel MA, Drexhage HA (2012b) The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes. J Leukoc Biol 92:959–975

    Article  CAS  PubMed  Google Scholar 

  • Birerdinc A, Afendy A, Stepanova M, Younossi I, Baranova A, Younossi ZM (2012) Gene expression profiles associated with depression in patients with chronic hepatitis C (CH-C). Brain Behav 2:525–531

    Article  PubMed  Google Scholar 

  • Bitanihirwe BK, Peleg-Raibstein D, Mouttet F, Feldon J, Meyer U (2010) Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol 35:2462–2478

    Article  CAS  Google Scholar 

  • Bluthe RM, Laye S, Michaud B, Combe C, Dantzer R, Parnet P (2000) Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice. Eur J Neurosci 12:4447–4456

    CAS  PubMed  Google Scholar 

  • Boksa P (2008) Maternal infection during pregnancy and schizophrenia. J Psychiatry Neurosci: JPN 33:183–185

    PubMed  Google Scholar 

  • Boksa P (2010) Effects of prenatal infection on brain development and behavior: a review of findings from animal models. Brain Behav Immun 24:881–897

    Article  PubMed  Google Scholar 

  • Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA: J Am Med Assoc 295:2275–2285

    Article  CAS  Google Scholar 

  • Braunschweig D, Van de Water J (2012) Maternal autoantibodies in autism. Arch Neurol 69:693–699

    Article  PubMed  Google Scholar 

  • Brown AS (2011) The environment and susceptibility to schizophrenia. Prog Neurobiol 93:23–58

    Article  CAS  PubMed  Google Scholar 

  • Brown AS, Derkits EJ (2010) Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 167:261–280

    Article  PubMed  Google Scholar 

  • Brown AS, Cohen P, Harkavy-Friedman J, Babulas V, Malaspina D, Gorman JM, Susser ES (2001) A.E. Bennett Research Award. Prenatal rubella, premorbid abnormalities, and adult schizophrenia. Biol Psychiatry 49:473–486

    Article  CAS  PubMed  Google Scholar 

  • Brown AS, Begg MD, Gravenstein S, Schaefer CA, Wyatt RJ, Bresnahan M, Babulas VP, Susser ES (2004a) Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 61:774–780

    Article  PubMed  Google Scholar 

  • Brown AS, Hooton J, Schaefer CA, Zhang H, Petkova E, Babulas V, Perrin M, Gorman JM, Susser ES (2004b) Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry 161:889–895

    Article  PubMed  Google Scholar 

  • Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Wagner RL, Yolken RH (2001) Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav Immun 15:411–420

    Article  CAS  PubMed  Google Scholar 

  • Buka SL, Cannon TD, Torrey EF, Yolken RH (2008) Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring. Biol Psychiatry 63:809–815

    Article  PubMed  Google Scholar 

  • Busse S, Busse M, Schiltz K, Bielau H, Gos T, Brisch R, Mawrin C, Schmitt A, Jordan W, Muller UJ, Bernstein HG, Bogerts B, Steiner J (2012) Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: further evidence for disease course-related immune alterations? Brain Behav Immun 26:1273–1279

    Article  CAS  PubMed  Google Scholar 

  • Capuron L, Ravaud A, Dantzer R (2000) Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. J Clin Oncol: Off J Am Soc Clin Oncol 18:2143–2151

    CAS  Google Scholar 

  • Capuron L, Ravaud A, Gualde N, Bosmans E, Dantzer R, Maes M, Neveu PJ (2001) Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology 26:797–808

    Article  CAS  PubMed  Google Scholar 

  • Capuron L, Ravaud A, Neveu PJ, Miller AH, Maes M, Dantzer R (2002) Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry 7:468–473

    Article  CAS  PubMed  Google Scholar 

  • Capuron L, Neurauter G, Musselman DL, Lawson DH, Nemeroff CB, Fuchs D, Miller AH (2003) Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. Biol Psychiatry 54:906–914

    Article  CAS  PubMed  Google Scholar 

  • Capuron L, Ravaud A, Miller AH, Dantzer R (2004) Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy. Brain Behav Immun 18:205–213

    Article  CAS  PubMed  Google Scholar 

  • Carta MG, Loviselli A, Hardoy MC, Massa S, Cadeddu M, Sardu C, Carpiniello B, Dell’Osso L, Mariotti S (2004) The link between thyroid autoimmunity (antithyroid peroxidase autoantibodies) with anxiety and mood disorders in the community: a field of interest for public health in the future. BMC Psychiatry 4:25

    Article  PubMed  CAS  Google Scholar 

  • Carta MG, Hardoy MC, Carpiniello B, Murru A, Marci AR, Carbone F, Deiana L, Cadeddu M, Mariotti S (2005) A case control study on psychiatric disorders in Hashimoto disease and Euthyroid Goitre: not only depressive but also anxiety disorders are associated with thyroid autoimmunity. Clin Pract Epidemiol Ment Health 1:23

    Article  PubMed  Google Scholar 

  • Cazzullo CL, Sacchetti E, Galluzzo A, Panariello A, Adorni A, Pegoraro M, Bosis S, Colombo F, Trabattoni D, Zagliani A, Clerici M (2002) Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study. Prog Neuro-psychopharmacol Biol Psychiatry 26:33–39

    Article  CAS  Google Scholar 

  • Chaves C, Marque CR, Trzesniak C, Machado de Sousa JP, Zuardi AW, Crippa JA, Dursun SM, Hallak JE (2009) Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizophrenia: an update. Braz J Med Biol Res = Rev Bras Pesquisas Med Biols/Soc Bras Biofisica [et al] 42:1002–1014

    CAS  Google Scholar 

  • Chen SL, Lee SY, Chang YH, Chen SH, Chu CH, Tzeng NS, Lee IH, Chen PS, Yeh TL, Huang SY, Yang YK, Lu RB (2012) Inflammation in patients with schizophrenia: the therapeutic benefits of risperidone plus add-on dextromethorphan. J Neuroimmune Pharmacol: Off J Soc NeuroImmune Pharmacol 7:656–664

    Article  Google Scholar 

  • Chez MG, Dowling T, Patel PB, Khanna P, Kominsky M (2007) Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children. Pediatr Neurol 36:361–365

    Article  PubMed  Google Scholar 

  • Chowdari KV, Xu K, Zhang F, Ma C, Li T, Xie BY, Wood J, Trucco M, Tsoi WF, Saha N, Rudert WA, Nimgaonkar VL (2001) Immune related genetic polymorphisms and schizophrenia among the Chinese. Hum Immunol 62:714–724

    Article  CAS  PubMed  Google Scholar 

  • Christmas DM, Potokar J, Davies SJ (2011) A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase. Neuropsychiatr Dis Treat 7:431–439

    CAS  PubMed  Google Scholar 

  • Clancy B, Finlay BL, Darlington RB, Anand KJ (2007) Extrapolating brain development from experimental species to humans. Neurotoxicology 28:931–937

    Article  PubMed  Google Scholar 

  • Connor TJ, Leonard BE (1998) Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci 62:583–606

    Article  CAS  PubMed  Google Scholar 

  • Corona AW, Norden DM, Skendelas JP, Huang Y, O’Connor JC, Lawson M, Dantzer R, Kelley KW, Godbout JP (2012) Indoleamine 2,3-dioxygenase inhibition attenuates lipopolysaccharide induced persistent microglial activation and depressive-like complications in fractalkine receptor (CX(3)CR1)-deficient mice. Brain Behav Immun. doi:10.1016/j.bbi.2012.08.008

  • Covic T, Cumming SR, Pallant JF, Manolios N, Emery P, Conaghan PG, Tennant A (2012) Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the hospital, Anxiety and Depression Scale (HADS). BMC Psychiatry 12:6

    Article  PubMed  Google Scholar 

  • Craddock RM, Lockstone HE, Rider DA, Wayland MT, Harris LJ, McKenna PJ, Bahn S (2007) Altered T-cell function in schizophrenia: a cellular model to investigate molecular disease mechanisms. PLoS One 2:e692

    Article  PubMed  CAS  Google Scholar 

  • Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46–56

    Article  CAS  PubMed  Google Scholar 

  • Dantzer R, O’Connor JC, Lawson MA, Kelley KW (2011) Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology 36:426–436

    Article  CAS  PubMed  Google Scholar 

  • Debnath M, Cannon DM, Venkatasubramanian G (2013) Variation in the major histocompatibility complex [MHC] gene family in schizophrenia: associations and functional implications. Prog Neuro-psychopharmacol Biol Psychiatry 42:49–62

  • Dempsey PW, Vaidya SA, Cheng G (2003) The art of war: Innate and adaptive immune responses. Cell Mol Life Sci: CMLS 60:2604–2621

    Article  CAS  PubMed  Google Scholar 

  • Depino AM (2013) Peripheral and central inflammation in autism spectrum disorders. Mol Cell Neurosci 53:69–76

    Google Scholar 

  • Dickens C, McGowan L, Clark-Carter D, Creed F (2002) Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychosom Med 64:52–60

    PubMed  Google Scholar 

  • Doorduin J, de Vries EF, Willemsen AT, de Groot JC, Dierckx RA, Klein HC (2009) Neuroinflammation in schizophrenia-related psychosis: a PET study. J Nucl Med: Off Publ, Soc Nucl Med 50:1801–1807

    Google Scholar 

  • Douglas KM, Taylor AJ, O’Malley PG (2004) Relationship between depression and C-reactive protein in a screening population. Psychosom Med 66:679–683

    Article  CAS  PubMed  Google Scholar 

  • Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctot KL (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67:446–457

    Article  CAS  PubMed  Google Scholar 

  • Drexhage RC, Padmos RC, de Wit H, Versnel MA, Hooijkaas H, van der Lely AJ, van Beveren N, deRijk RH, Cohen D (2008) Patients with schizophrenia show raised serum levels of the pro-inflammatory chemokine CCL2: association with the metabolic syndrome in patients? Schizophr Res 102:352–355

    Article  PubMed  Google Scholar 

  • Drexhage RC, van der Heul-Nieuwenhuijsen L, Padmos RC, van Beveren N, Cohen D, Versnel MA, Nolen WA, Drexhage HA (2010) Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients. Int J Neuropsychopharmacol 13:1369–1381

    Article  CAS  PubMed  Google Scholar 

  • Drexhage RC, Hoogenboezem TA, Cohen D, Versnel MA, Nolen WA, van Beveren NJ, Drexhage HA (2011) An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces. Int J Neuropsychopharmacol 14:746–755

    Article  CAS  PubMed  Google Scholar 

  • Duivis HE, de Jonge P, Penninx BW, Na BY, Cohen BE, Whooley MA (2011) Depressive symptoms, health behaviors, and subsequent inflammation in patients with coronary heart disease: prospective findings from the heart and soul study. Am J Psychiatry 168:913–920

    Article  PubMed  Google Scholar 

  • Duivis HE, Kupper N, Penninx BW, Na B, de Jonge P, Whooley MA (2012) Depressive symptoms and white blood cell count in coronary heart disease patients: prospective findings from the Heart and Soul Study. Psychoneuroendocrinology 35(4):479–487

    Google Scholar 

  • Duman RS, Aghajanian GK (2012) Synaptic dysfunction in depression: potential therapeutic targets. Science 338:68–72

    Article  CAS  PubMed  Google Scholar 

  • Dunn AJ, Swiergiel AH, de Beaurepaire R (2005) Cytokines as mediators of depression: what can we learn from animal studies? Neurosci Biobehav Rev 29:891–909

    Article  CAS  PubMed  Google Scholar 

  • Eaton WW, Byrne M, Ewald H, Mors O, Chen CY, Agerbo E, Mortensen PB (2006) Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry 163:521–528

    Article  PubMed  Google Scholar 

  • Eaton WW, Pedersen MG, Nielsen PR, Mortensen PB (2010) Autoimmune diseases, bipolar disorder, and non-affective psychosis. Bipolar Disord 12:638–646

    Article  PubMed  Google Scholar 

  • Eller T, Vasar V, Shlik J, Maron E (2009) The role of IL-2 and soluble IL-2R in depression and antidepressant response. Curr Opin Investig Drugs 10:638–643

    CAS  PubMed  Google Scholar 

  • Ellman LM, Deicken RF, Vinogradov S, Kremen WS, Poole JH, Kern DM, Tsai WY, Schaefer CA, Brown AS (2010) Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8. Schizophr Res 121:46–54

    Article  PubMed  Google Scholar 

  • Enstrom AM, Onore CE, Van de Water JA, Ashwood P (2010) Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun 24:64–71

    Article  CAS  PubMed  Google Scholar 

  • Ertenli I, Ozer S, Kiraz S, Apras SB, Akdogan A, Karadag O, Calguneri M, Kalyoncu U (2012) Infliximab, a TNF-alpha antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level. Rheumatol Int 32:323–330

    Article  CAS  PubMed  Google Scholar 

  • Evans DL, Ten Have TR, Douglas SD, Gettes DR, Morrison M, Chiappini MS, Brinker-Spence P, Job C, Mercer DE, Wang YL, Cruess D, Dube B, Dalen EA, Brown T, Bauer R, Petitto JM (2002) Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am J Psychiatry 159:1752–1759

    Article  PubMed  Google Scholar 

  • Eyles D, Feldon J, Meyer U (2012) Schizophrenia: do all roads lead to dopamine or is this where they start? Evidence from two epidemiologically informed developmental rodent models. Transl Psychiatry 2:e81

    Article  CAS  PubMed  Google Scholar 

  • Fatemi SH, Reutiman TJ, Folsom TD, Huang H, Oishi K, Mori S, Smee DF, Pearce DA, Winter C, Sohr R, Juckel G (2008) Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders. Schizophr Res 99:56–70

    Article  PubMed  Google Scholar 

  • Fatjo-Vilas M, Pomarol-Clotet E, Salvador R, Monte GC, Gomar JJ, Sarro S, Ortiz-Gil J, Aguirre C, Landin-Romero R, Guerrero-Pedraza A, Papiol S, Blanch J, McKenna PJ, Fananas L (2012) Effect of the interleukin-1beta gene on dorsolateral prefrontal cortex function in schizophrenia: a genetic neuroimaging study. Biol Psychiatry 72:758–765

    Article  CAS  PubMed  Google Scholar 

  • Feldman SR, Gottlieb AB, Bala M, Wu Y, Eisenberg D, Guzzo C, Li S, Dooley LT, Menter A (2008) Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis. Br J Dermatol 159:704–710

    Article  CAS  PubMed  Google Scholar 

  • Fields C, Drye L, Vaidya V, Lyketsos C (2012) Celecoxib or naproxen treatment does not benefit depressive symptoms in persons age 70 and older: findings from a randomized controlled trial. Am J Geriatr Psychiatr: Off J Am Assoc Geriatr Psychiatr 20:505–513

    Article  Google Scholar 

  • Fillman SG, Cloonan N, Catts VS, Miller LC, Wong J, McCrossin T, Cairns M, Weickert CS (2013) Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry 18(2)206–214

    Google Scholar 

  • Fischler B, Bocken R, Schneider I, De Waele M, Thielemans K, Derde MP (1992) Immune changes induced by electroconvulsive therapy (ECT). Ann N Y Acad Sci 650:326–330

    Article  CAS  PubMed  Google Scholar 

  • Fluitman SB, Heijnen CJ, Denys DA, Nolen WA, Balk FJ, Westenberg HG (2011) Electroconvulsive therapy has acute immunological and neuroendocrine effects in patients with major depressive disorder. J Affect Disord 131:388–392

    Article  CAS  PubMed  Google Scholar 

  • Forrest CM, Khalil OS, Pisar M, Smith RA, Darlington LG, Stone TW (2012) Prenatal activation of Toll-like receptors-3 by administration of the viral mimetic poly(I:C) changes synaptic proteins, N-methyl-D-aspartate receptors and neurogenesis markers in offspring. Mol Brain 5:22

    Article  CAS  PubMed  Google Scholar 

  • Freidin M, Bennett MV, Kessler JA (1992) Cultured sympathetic neurons synthesize and release the cytokine interleukin 1 beta. Proc Natl Acad Sci U S A 89:10440–10443

    Article  CAS  PubMed  Google Scholar 

  • Frodl T, Carballedo A, Hughes MM, Saleh K, Fagan A, Skokauskas N, McLoughlin DM, Meaney J, O’Keane V, Connor TJ (2012) Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: high IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder. Transl Psychiatry 2:e88

    Article  CAS  PubMed  Google Scholar 

  • Fu X, Zunich SM, O’Connor JC, Kavelaars A, Dantzer R, Kelley KW (2010) Central administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures. J Neuroinflammation 7:43

    Article  PubMed  CAS  Google Scholar 

  • Garden GA, Moller T (2006) Microglia biology in health and disease. J Neuroimmune Pharmacol: Off J Soc NeuroImmune Pharmacol 1:127–137

    Article  Google Scholar 

  • Gibney SM, McGuinness B, Prendergast C, Harkin A, Connor TJ (2013) Poly I:C-induced activation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression. Brain Behavior Immun 28:170–181

    Google Scholar 

  • Godha D, Shi L, Mavronicolas H (2010) Association between tendency towards depression and severity of rheumatoid arthritis from a national representative sample: the Medical Expenditure Panel Survey. Curr Med Res Opin 26:1685–1690

    Article  PubMed  Google Scholar 

  • Golan HM, Lev V, Hallak M, Sorokin Y, Huleihel M (2005) Specific neurodevelopmental damage in mice offspring following maternal inflammation during pregnancy. Neuropharmacology 48:903–917

    Article  CAS  PubMed  Google Scholar 

  • Graciarena M, Depino AM, Pitossi FJ (2010) Prenatal inflammation impairs adult neurogenesis and memory related behavior through persistent hippocampal TGFbeta1 downregulation. Brain Behav Immun 24:1301–1309

    Article  CAS  PubMed  Google Scholar 

  • Grigoleit JS, Kullmann JS, Wolf OT, Hammes F, Wegner A, Jablonowski S, Engler H, Gizewski E, Oberbeck R, Schedlowski M (2011) Dose-dependent effects of endotoxin on neurobehavioral functions in humans. PLoS One 6:e28330

    Article  CAS  PubMed  Google Scholar 

  • Guo JY, Li CY, Ruan YP, Sun M, Qi XL, Zhao BS, Luo F (2009) Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain. Eur J Pharmacol 612:54–60

    Article  CAS  PubMed  Google Scholar 

  • Hanisch UK (2002) Microglia as a source and target of cytokines. Glia 40:140–155

    Article  PubMed  Google Scholar 

  • Hannestad J, DellaGioia N, Bloch M (2011) The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol 36:2452–2459

    Article  CAS  Google Scholar 

  • Hanninen K, Katila H, Saarela M, Rontu R, Mattila KM, Fan M, Hurme M, Lehtimaki T (2008) Interleukin-1 beta gene polymorphism and its interactions with neuregulin-1 gene polymorphism are associated with schizophrenia. Eur Arch Psychiatr Clin Neurosci 258:10–15

    Google Scholar 

  • Hao LY, Hao XQ, Li SH, Li XH (2010) Prenatal exposure to lipopolysaccharide results in cognitive deficits in age-increasing offspring rats. Neuroscience 166:763–770

    Article  CAS  PubMed  Google Scholar 

  • Hayley S, Scharf J, Anisman H (2012) Central administration of murine interferon-alpha induces depressive-like behavioral, brain cytokine and neurochemical alterations in mice: a mini-review and original experiments. Brain Behav Immun. doi:10.1016/j.bbi.2012.07.023

  • Herbert J, Goodyer IM, Grossman AB, Hastings MH, de Kloet ER, Lightman SL, Lupien SJ, Roozendaal B, Seckl JR (2006a) Do corticosteroids damage the brain? J Neuroendocrinol 18:393–411

    Article  CAS  PubMed  Google Scholar 

  • Herbert MR, Russo JP, Yang S, Roohi J, Blaxill M, Kahler SG, Cremer L, Hatchwell E (2006b) Autism and environmental genomics. Neurotoxicology 27:671–684

    Article  CAS  PubMed  Google Scholar 

  • Hestad KA, Tonseth S, Stoen CD, Ueland T, Aukrust P (2003) Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy. J ECT 19:183–188

    Article  PubMed  Google Scholar 

  • Hillegers MH, Reichart CG, Wals M, Verhulst FC, Ormel J, Nolen WA, Drexhage HA (2007) Signs of a higher prevalence of autoimmune thyroiditis in female offspring of bipolar parents. Eur Neuropsychopharmacol: J Eur Coll Neuropsychopharmacol 17:394–399

    Article  CAS  Google Scholar 

  • Himmerich H, Milenovic S, Fulda S, Plumakers B, Sheldrick AJ, Michel TM, Kircher T, Rink L (2010) Regulatory T cells increased while IL-1beta decreased during antidepressant therapy. J Psychiatr Res 44:1052–1057

    Article  PubMed  Google Scholar 

  • Hinwood M, Morandini J, Day TA, Walker FR (2012) Evidence that microglia mediate the neurobiological effects of chronic psychological stress on the medial prefrontal cortex. Cereb Cortex 22:1442–1454

    Article  CAS  PubMed  Google Scholar 

  • Hopkins SJ, Rothwell NJ (1995) Cytokines and the nervous system. I: expression and recognition. Trends Neurosci 18:83–88

    Article  CAS  PubMed  Google Scholar 

  • Howren MB, Lamkin DM, Suls J (2009) Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71:171–186

    Article  CAS  PubMed  Google Scholar 

  • Hsiao EY, McBride SW, Chow J, Mazmanian SK, Patterson PH (2012) Modeling an autism risk factor in mice leads to permanent immune dysregulation. Proc Natl Acad Sci U S A 109:12776–12781

    Article  CAS  PubMed  Google Scholar 

  • Hughes MM, Carballedo A, McLoughlin DM, Amico F, Harkin A, Frodl T, Connor TJ (2012) Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation. Brain Behav Immun 26:979–987

    Article  CAS  PubMed  Google Scholar 

  • Ibi D, Nagai T, Koike H, Kitahara Y, Mizoguchi H, Niwa M, Jaaro-Peled H, Nitta A, Yoneda Y, Nabeshima T, Sawa A, Yamada K (2010) Combined effect of neonatal immune activation and mutant DISC1 on phenotypic changes in adulthood. Behav Brain Res 206:32–37

    Article  CAS  PubMed  Google Scholar 

  • Irish Schizophrenia Genomics Consortium and the Wellcome Trust Case Control Consortium (2012) Genome-wide association study implicates HLA-C*01:02 as a risk factor at the major histocompatibility complex locus in schizophrenia. Biol Psychiatry 72:620–628

    Article  CAS  Google Scholar 

  • Jia P, Wang L, Fanous AH, Pato CN, Edwards TL, Zhao Z (2012a) Network-assisted investigation of combined causal signals from genome-wide association studies in schizophrenia. PLoS Comput Biol 8:e1002587

    Article  CAS  PubMed  Google Scholar 

  • Jia P, Wang L, Fanous AH, Chen X, Kendler KS, Zhao Z (2012b) A bias-reducing pathway enrichment analysis of genome-wide association data confirmed association of the MHC region with schizophrenia. J Med Genet 49:96–103

    Article  CAS  PubMed  Google Scholar 

  • Johansson D, Falk A, Marcus MM, Svensson TH (2012) Celecoxib enhances the effect of reboxetine and fluoxetine on cortical noradrenaline and serotonin output in the rat. Prog Neuro-psychopharmacol Biol Psychiatr 39:143–148

    Article  CAS  Google Scholar 

  • Jyonouchi H, Geng L, Streck DL, Toruner GA (2012) Immunological characterization and transcription profiling of peripheral blood (PB) monocytes in children with autism spectrum disorders (ASD) and specific polysaccharide antibody deficiency (SPAD): case study. J Neuroinflammation 9:4

    Article  CAS  PubMed  Google Scholar 

  • Kaster MP, Gadotti VM, Calixto JB, Santos AR, Rodrigues AL (2012) Depressive-like behavior induced by tumor necrosis factor-alpha in mice. Neuropharmacology 62:419–426

    Article  CAS  PubMed  Google Scholar 

  • Katila H, Hurme M, Wahlbeck K, Appelberg B, Rimon R (1994) Plasma and cerebrospinal fluid interleukin-1 beta and interleukin-6 in hospitalized schizophrenic patients. Neuropsychobiology 30:20–23

    Article  CAS  PubMed  Google Scholar 

  • Katz PP, Yelin EH (2001) Activity loss and the onset of depressive symptoms: do some activities matter more than others? Arthritis Rheum 44:1194–1202

    Article  CAS  PubMed  Google Scholar 

  • Kelly DL, Vyas G, Richardson CM, Koola M, McMahon RP, Buchanan RW, Wehring HJ (2011) Adjunct minocycline to clozapine treated patients with persistent schizophrenia symptoms. Schizophr Res 133:257–258

    Article  PubMed  Google Scholar 

  • Kettenmann H, Hanisch UK, Noda M, Verkhratsky A (2011) Physiology of microglia. Physiol Rev 91:461–553

    Article  CAS  PubMed  Google Scholar 

  • Kitazawa M, Cheng D, Tsukamoto MR, Koike MA, Wes PD, Vasilevko V, Cribbs DH, LaFerla FM (2011) Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal beta-catenin pathway function in an Alzheimer’s disease model. J Immunol 187:6539–6549

    Article  CAS  PubMed  Google Scholar 

  • Kolvin I (1971) Studies in the childhood psychoses. I. Diagnostic criteria and classification. Br J Psychiatry: J Mental Sci 118:381–384

    Article  CAS  Google Scholar 

  • Kraus MR, Schafer A, Schottker K, Keicher C, Weissbrich B, Hofbauer I, Scheurlen M (2008) Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study. Gut 57:531–536

    Article  CAS  PubMed  Google Scholar 

  • Krishnadas R, Cavanagh J (2012) Depression: an inflammatory illness? J Neurol Neurosurg Psychiatry 83:495–502

    Article  PubMed  Google Scholar 

  • Krishnan R, Cella D, Leonardi C, Papp K, Gottlieb AB, Dunn M, Chiou CF, Patel V, Jahreis A (2007) Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks. Br J Dermatol 157:1275–1277

    Article  CAS  PubMed  Google Scholar 

  • Kronfol Z, Remick DG (2000) Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 157:683–694

    Article  CAS  PubMed  Google Scholar 

  • Kronfol Z, Nair MP, Weinberg V, Young EA, Aziz M (2002) Acute effects of electroconvulsive therapy on lymphocyte natural killer cell activity in patients with major depression. J Affect Disord 71:211–215

    Article  PubMed  Google Scholar 

  • Kubera M, Obuchowicz E, Goehler L, Brzeszcz J, Maes M (2011) In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression. Prog Neuro-psychopharmacol Biol Psychiatr 35:744–759

    Article  CAS  Google Scholar 

  • Kupka RW, Nolen WA, Post RM, McElroy SL, Altshuler LL, Denicoff KD, Frye MA, Keck PE Jr, Leverich GS, Rush AJ, Suppes T, Pollio C, Drexhage HA (2002) High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure. Biol Psychiatry 51:305–311

    Article  CAS  PubMed  Google Scholar 

  • Kupper N, Widdershoven JW, Pedersen SS (2012) Cognitive/affective and somatic/affective symptom dimensions of depression are associated with current and future inflammation in heart failure patients. J Affect Disord 136:567–576

    Article  PubMed  Google Scholar 

  • Laurent C, Thibaut F, Ravassard P, Campion D, Samolyk D, Lafargue C, Petit M, Martinez M, Mallet J (1997) Detection of two new polymorphic sites in the human interleukin-1 beta gene: lack of association with schizophrenia in a French population. Psychiatr Genet 7:103–105

    Article  CAS  PubMed  Google Scholar 

  • Lehman CL, Cheung RC (2002) Depression, anxiety, post-traumatic stress, and alcohol-related problems among veterans with chronic hepatitis C. Am J Gastroenterol 97:2640–2646

    Article  PubMed  Google Scholar 

  • Lehtimaki K, Keranen T, Huuhka M, Palmio J, Hurme M, Leinonen E, Peltola J (2008) Increase in plasma proinflammatory cytokines after electroconvulsive therapy in patients with depressive disorder. J ECT 24:88–91

    Article  PubMed  Google Scholar 

  • Levkovitz Y, Mendlovich S, Riwkes S, Braw Y, Levkovitch-Verbin H, Gal G, Fennig S, Treves I, Kron S (2010) A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. J Clin Psychiatry 71:138–149

    Article  CAS  PubMed  Google Scholar 

  • Levy BH, Tasker JG (2012) Synaptic regulation of the hypothalamic-pituitary-adrenal axis and its modulation by glucocorticoids and stress. Front Cell Neurosci 6:24

    Article  CAS  PubMed  Google Scholar 

  • Li Q, Cheung C, Wei R, Hui ES, Feldon J, Meyer U, Chung S, Chua SE, Sham PC, Wu EX, McAlonan GM (2009a) Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant to schizophrenia: evidence from MRI in a mouse model. PLoS One 4:e6354

    Article  PubMed  CAS  Google Scholar 

  • Li X, Chauhan A, Sheikh AM, Patil S, Chauhan V, Li XM, Ji L, Brown T, Malik M (2009b) Elevated immune response in the brain of autistic patients. J Neuroimmunol 207:111–116

    Article  CAS  PubMed  Google Scholar 

  • Li Q, Cheung C, Wei R, Cheung V, Hui ES, You Y, Wong P, Chua SE, McAlonan GM, Wu EX (2010) Voxel-based analysis of postnatal white matter microstructure in mice exposed to immune challenge in early or late pregnancy. NeuroImage 52:1–8

    Article  CAS  PubMed  Google Scholar 

  • Liu L, Jia F, Yuan G, Chen Z, Yao J, Li H, Fang C (2010) Tyrosine hydroxylase, interleukin-1beta and tumor necrosis factor-alpha are overexpressed in peripheral blood mononuclear cells from schizophrenia patients as determined by semi-quantitative analysis. Psychiatry Res 176:1–7

    Article  CAS  PubMed  Google Scholar 

  • Loftis JM, Huckans M, Ruimy S, Hinrichs DJ, Hauser P (2008) Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factor-alpha. Neurosci Lett 430:264–268

    Article  CAS  PubMed  Google Scholar 

  • Lu LX, Guo SQ, Chen W, Li Q, Cheng J, Guo JH (2004) [Effect of clozapine and risperidone on serum cytokine levels in patients with first-episode paranoid schizophrenia]. Di 1 jun yi da xue xue bao = Acad J First Med Coll PLA 24:1251–1254

    Google Scholar 

  • Maes M, Bosmans E, Ranjan R, Vandoolaeghe E, Meltzer HY, De Ley M, Berghmans R, Stans G, Desnyder R (1996) Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs. Schizophr Res 21:39–50

    Article  CAS  PubMed  Google Scholar 

  • Maes M, Bosmans E, Kenis G, De Jong R, Smith RS, Meltzer HY (1997) In vivo immunomodulatory effects of clozapine in schizophrenia. Schizophr Res 26:221–225

    Article  CAS  PubMed  Google Scholar 

  • Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R (2011) The new ‘5-HT’ hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuro-psychopharmacol Biol Psychiatry 35:702–721

    Article  CAS  Google Scholar 

  • Malkova NV, Yu CZ, Hsiao EY, Moore MJ, Patterson PH (2012) Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism. Brain Behav Immun 26:607–616

    Article  CAS  PubMed  Google Scholar 

  • Manev R, Manev H (2009) Minocycline, schizophrenia and GluR1 glutamate receptors. Progr Neuro-psychopharmacol Biol Psychiatry 33:166, author reply 167

    Article  CAS  Google Scholar 

  • Margaretten M, Julian L, Katz P, Yelin E (2011) Depression in patients with rheumatoid arthritis: description, causes and mechanisms. Int J Clin Rheumatol 6:617–623

    Article  Google Scholar 

  • Matsumoto Y, Yamaguchi T, Watanabe S, Yamamoto T (2004) Involvement of arachidonic acid cascade in working memory impairment induced by interleukin-1 beta. Neuropharmacology 46:1195–1200

    Article  CAS  PubMed  Google Scholar 

  • Mednick SA, Machon RA, Huttunen MO, Bonett D (1988) Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 45:189–192

    Article  CAS  PubMed  Google Scholar 

  • Meijer A, Conradi HJ, Bos EH, Thombs BD, van Melle JP, de Jonge P (2011) Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry 33:203–216

    Article  PubMed  Google Scholar 

  • Meyer U, Feldon J (2009) Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia. Psychopharmacology 206:587–602

    Article  CAS  PubMed  Google Scholar 

  • Meyer U, Feldon J (2012) To poly(I:C) or not to poly(I:C): advancing preclinical schizophrenia research through the use of prenatal immune activation models. Neuropharmacology 62:1308–1321

    Article  CAS  PubMed  Google Scholar 

  • Meyer U, Nyffeler M, Engler A, Urwyler A, Schedlowski M, Knuesel I, Yee BK, Feldon J (2006) The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosc: Offi J Soc Neurosci 26:4752–4762

    Article  CAS  Google Scholar 

  • Meyer U, Feldon J, Yee BK (2009) A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr Bull 35:959–972

    Article  PubMed  Google Scholar 

  • Meyer U, Spoerri E, Yee BK, Schwarz MJ, Feldon J (2010) Evaluating early preventive antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia. Schizophr Bull 36:607–623

    Article  PubMed  Google Scholar 

  • Meyer U, Feldon J, Dammann O (2011) Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation? Pediatr Res 69:26R–33R

    Article  PubMed  Google Scholar 

  • Miller AH, Maletic V, Raison CL (2009) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65:732–741

    Article  CAS  PubMed  Google Scholar 

  • Miller AH, Haroon E, Raison CL, Felger JC (2013) Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depression Anxiety 30(4):297–306

    Google Scholar 

  • Miyaoka T, Yasukawa R, Yasuda H, Hayashida M, Inagaki T, Horiguchi J (2008) Minocycline as adjunctive therapy for schizophrenia: an open-label study. Clin Neuropharmacol 31:287–292

    Article  CAS  PubMed  Google Scholar 

  • Molloy CA, Morrow AL, Meinzen-Derr J, Schleifer K, Dienger K, Manning-Courtney P, Altaye M, Wills-Karp M (2006) Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol 172:198–205

    Article  CAS  PubMed  Google Scholar 

  • Morgan JT, Chana G, Pardo CA, Achim C, Semendeferi K, Buckwalter J, Courchesne E, Everall IP (2010) Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol Psychiatry 68:368–376

    Article  PubMed  Google Scholar 

  • Morgan JT, Chana G, Abramson I, Semendeferi K, Courchesne E, Everall IP (2012) Abnormal microglial-neuronal spatial organization in the dorsolateral prefrontal cortex in autism. Brain Res 1456:72–81

    Article  CAS  PubMed  Google Scholar 

  • Mortensen PB, Pedersen CB, Hougaard DM, Norgaard-Petersen B, Mors O, Borglum AD, Yolken RH (2010) A Danish National Birth Cohort study of maternal HSV-2 antibodies as a risk factor for schizophrenia in their offspring. Schizophr Res 122:257–263

    Article  PubMed  Google Scholar 

  • Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B (2007) Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 370:851–858

    Article  PubMed  Google Scholar 

  • Muller N, Riedel M, Scheppach C, Brandstatter B, Sokullu S, Krampe K, Ulmschneider M, Engel RR, Moller HJ, Schwarz MJ (2002) Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. Am J Psychiatry 159:1029–1034

    Article  PubMed  Google Scholar 

  • Muller N, Riedel M, Schwarz MJ, Engel RR (2005) Clinical effects of COX-2 inhibitors on cognition in schizophrenia. Eur Arch Psychiatr Clin Neurosci 255:149–151

    Article  Google Scholar 

  • Muller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-Muller B, Spellmann I, Hetzel G, Maino K, Kleindienst N, Moller HJ, Arolt V, Riedel M (2006) The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry 11:680–684

    Article  CAS  PubMed  Google Scholar 

  • Muller N, Krause D, Dehning S, Musil R, Schennach-Wolff R, Obermeier M, Moller HJ, Klauss V, Schwarz MJ, Riedel M (2010) Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment. Schizophr Res 121:118–124

    Article  PubMed  Google Scholar 

  • Muller N, Wagner JK, Krause D, Weidinger E, Wildenauer A, Obermeier M, Dehning S, Gruber R, Schwarz MJ (2012) Impaired monocyte activation in schizophrenia. Psychiatry Res 198:341–346

    Article  PubMed  CAS  Google Scholar 

  • Musil R, Schwarz MJ, Riedel M, Dehning S, Cerovecki A, Spellmann I, Arolt V, Muller N (2011) Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression–no influence of celecoxib treatment. J Affect Disord 134:217–225

    Article  CAS  PubMed  Google Scholar 

  • Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S, Goodkin RS, Greiner K, Nemeroff CB, Miller AH (2001) Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 344:961–966

    Article  CAS  PubMed  Google Scholar 

  • Myint AM, Steinbusch HW, Goeghegan L, Luchtman D, Kim YK, Leonard BE (2007a) Effect of the COX-2 inhibitor celecoxib on behavioural and immune changes in an olfactory bulbectomised rat model of depression. Neuroimmunomodulation 14:65–71

    Article  CAS  PubMed  Google Scholar 

  • Myint AM, O’Mahony S, Kubera M, Kim YK, Kenny C, Kaim-Basta A, Steinbusch HW, Leonard BE (2007b) Role of paroxetine in interferon-alpha-induced immune and behavioural changes in male Wistar rats. J Psychopharmacol 21:843–850

    Article  CAS  PubMed  Google Scholar 

  • Nagai T, Kitahara Y, Ibi D, Nabeshima T, Sawa A, Yamada K (2011) Effects of antipsychotics on the behavioral deficits in human dominant-negative DISC1 transgenic mice with neonatal polyI:C treatment. Behav Brain Res 225:305–310

    Article  CAS  PubMed  Google Scholar 

  • Nawa H, Takei N (2006) Recent progress in animal modeling of immune inflammatory processes in schizophrenia: implication of specific cytokines. Neurosci Res 56:2–13

    Article  CAS  PubMed  Google Scholar 

  • O’Callaghan E, Gibson T, Colohan HA, Walshe D, Buckley P, Larkin C, Waddington JL (1991) Season of birth in schizophrenia. Evidence for confinement of an excess of winter births to patients without a family history of mental disorder. Br J Psychiatr: J Mental Sci 158:764–769

    Article  Google Scholar 

  • O’Connor JC, Lawson MA, Andre C, Moreau M, Lestage J, Castanon N, Kelley KW, Dantzer R (2009a) Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 14:511–522

    Article  PubMed  CAS  Google Scholar 

  • O’Connor JC, Andre C, Wang Y, Lawson MA, Szegedi SS, Lestage J, Castanon N, Kelley KW, Dantzer R (2009b) Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J Neurosci: Off J Soc Neurosci 29:4200–4209

    Article  CAS  Google Scholar 

  • O’Connor JC, Lawson MA, Andre C, Briley EM, Szegedi SS, Lestage J, Castanon N, Herkenham M, Dantzer R, Kelley KW (2009c) Induction of IDO by bacille Calmette-Guerin is responsible for development of murine depressive-like behavior. J Immunol 182:3202–3212

    Article  PubMed  CAS  Google Scholar 

  • Oliver PL, Davies KE (2009) Interaction between environmental and genetic factors modulates schizophrenic endophenotypes in the Snap-25 mouse mutant blind-drunk. Hum Mol Genet 18:4576–4589

    Article  CAS  PubMed  Google Scholar 

  • Olson JK, Miller SD (2004) Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 173:3916–3924

    CAS  PubMed  Google Scholar 

  • Owen BM, Eccleston D, Ferrier IN, Young AH (2001) Raised levels of plasma interleukin-1beta in major and postviral depression. Acta Psychiatr Scand 103:226–228

    Article  CAS  PubMed  Google Scholar 

  • Padmos RC, Bekris L, Knijff EM, Tiemeier H, Kupka RW, Cohen D, Nolen WA, Lernmark A, Drexhage HA (2004) A high prevalence of organ-specific autoimmunity in patients with bipolar disorder. Biol Psychiatry 56:476–482

    Article  CAS  PubMed  Google Scholar 

  • Pan A, Ye X, Franco OH, Li H, Yu Z, Wang J, Qi Q, Gu W, Pang X, Liu H, Lin X (2008) The association of depressive symptoms with inflammatory factors and adipokines in middle-aged and older Chinese. PLoS One 3:e1392

    Article  PubMed  CAS  Google Scholar 

  • Paolicelli RC, Gross CT (2011) Microglia in development: linking brain wiring to brain environment. Neuron Glia Biol 7:77–83

    Article  PubMed  Google Scholar 

  • Papiol S, Rosa A, Gutierrez B, Martin B, Salgado P, Catalan R, Arias B, Fananas L (2004) Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder. J Med Genet 41:219–223

    Article  CAS  PubMed  Google Scholar 

  • Papiol S, Molina V, Desco M, Rosa A, Reig S, Gispert JD, Sanz J, Palomo T, Fananas L (2005) Ventricular enlargement in schizophrenia is associated with a genetic polymorphism at the interleukin-1 receptor antagonist gene. NeuroImage 27:1002–1006

    Article  PubMed  Google Scholar 

  • Patterson PH (2009) Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav Brain Res 204:313–321

    Article  CAS  PubMed  Google Scholar 

  • Patterson PH (2012) Maternal infection and autism. Brain Behav Immun 26:393

    Article  PubMed  Google Scholar 

  • Persoons P, Vermeire S, Demyttenaere K, Fischler B, Vandenberghe J, Van Oudenhove L, Pierik M, Hlavaty T, Van Assche G, Noman M, Rutgeerts P (2005) The impact of major depressive disorder on the short- and long-term outcome of Crohn’s disease treatment with infliximab. Aliment Pharmacol Ther 22:101–110

    Article  CAS  PubMed  Google Scholar 

  • Ping F, Shang J, Zhou J, Zhang H, Zhang L (2012) 5-HT(1A) receptor and apoptosis contribute to interferon-alpha-induced “depressive-like” behavior in mice. Neurosci Lett 514:173–178

    Article  CAS  PubMed  Google Scholar 

  • Piontkewitz Y, Arad M, Weiner I (2011) Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia. Schizophr Bull 37:1257–1269

    Article  PubMed  Google Scholar 

  • Piontkewitz Y, Bernstein HG, Dobrowolny H, Bogerts B, Weiner I, Keilhoff G (2012) Effects of risperidone treatment in adolescence on hippocampal neurogenesis, parvalbumin expression, and vascularization following prenatal immune activation in rats. Brain Behav Immun 26:353–363

    Article  CAS  PubMed  Google Scholar 

  • Pletnikov MV, Ayhan Y, Nikolskaia O, Xu Y, Ovanesov MV, Huang H, Mori S, Moran TH, Ross CA (2008) Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol Psychiatry 13:173–186, 115

    Article  CAS  PubMed  Google Scholar 

  • Purcell SM, Wray NR, Stone JL, Visscher PM, O’Donovan MC, Sullivan PF, Sklar P (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460:748–752

    CAS  PubMed  Google Scholar 

  • Quan N, Banks WA (2007) Brain-immune communication pathways. Brain Behav Immun 21:727–735

    Article  CAS  PubMed  Google Scholar 

  • Radewicz K, Garey LJ, Gentleman SM, Reynolds R (2000) Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics. J Neuropathol Exp Neurol 59:137–150

    CAS  PubMed  Google Scholar 

  • Raison CL, Miller AH (2011) Is depression an inflammatory disorder? Curr Psychiatry Rep 13:467–475

    Article  PubMed  Google Scholar 

  • Raison CL, Broadwell SD, Borisov AS, Manatunga AK, Capuron L, Woolwine BJ, Jacobson IM, Nemeroff CB, Miller AH (2005) Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C. Brain Behav Immun 19:23–27

    Article  CAS  PubMed  Google Scholar 

  • Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, Haroon E, Miller AH (2013) A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 70:31–41

    CAS  PubMed  Google Scholar 

  • Rapaport MH, McAllister CG, Pickar D, Tamarkin L, Kirch DG, Paul SM (1997) CSF IL-1 and IL-2 in medicated schizophrenic patients and normal volunteers. Schizophr Res 25:123–129

    Article  CAS  PubMed  Google Scholar 

  • Rapin I, Tuchman RF (2008) Autism: definition, neurobiology, screening, diagnosis. Pediatr Clin N Am 55:1129–1146, viii

    Article  Google Scholar 

  • Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, Pollmacher T (2001) Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58:445–452

    Article  CAS  PubMed  Google Scholar 

  • Reiner SL (2007) Development in motion: helper T cells at work. Cell 129:33–36

    Article  CAS  PubMed  Google Scholar 

  • Richtand NM, Ahlbrand R, Horn P, Stanford K, Bronson SL, McNamara RK (2011) Effects of risperidone and paliperidone pre-treatment on locomotor response following prenatal immune activation. J Psychiatr Res 45:1194–1201

    Article  PubMed  Google Scholar 

  • Richtand NM, Ahlbrand R, Horn P, Tambyraja R, Grainger M, Bronson SL, McNamara RK (2012) Fluoxetine and aripiprazole treatment following prenatal immune activation exert longstanding effects on rat locomotor response. Physiol Behav 106:171–177

    Article  CAS  PubMed  Google Scholar 

  • Riley JK, Nelson DM (2010) Toll-like receptors in pregnancy disorders and placental dysfunction. Clin Rev Allergy Immunol 39:185–193

    Article  CAS  PubMed  Google Scholar 

  • Roberts RC (2007) Schizophrenia in translation: disrupted in schizophrenia (DISC1): integrating clinical and basic findings. Schizophr Bull 33:11–15

    Article  PubMed  Google Scholar 

  • Roenker NL, Gudelsky G, Ahlbrand R, Bronson SL, Kern JR, Waterman H, Richtand NM (2011) Effect of paliperidone and risperidone on extracellular glutamate in the prefrontal cortex of rats exposed to prenatal immune activation or MK-801. Neurosci Lett 500:167–171

    Article  CAS  PubMed  Google Scholar 

  • Rothermundt M, Arolt V, Weitzsch C, Eckhoff D, Kirchner H (1998) Immunological dysfunction in schizophrenia: a systematic approach. Neuropsychobiology 37:186–193

    Article  CAS  PubMed  Google Scholar 

  • Saetre P, Emilsson L, Axelsson E, Kreuger J, Lindholm E, Jazin E (2007) Inflammation-related genes up-regulated in schizophrenia brains. BMC Psychiatry 7:46

    Article  PubMed  CAS  Google Scholar 

  • Saiz PA, Garcia-Portilla MP, Arango C, Morales B, Martinez-Barrondo S, Alvarez V, Coto E, Fernandez J, Bousono M, Bobes J (2006) Interleukin-1 gene complex in schizophrenia: an association study. Am J Medic Genet Part B, Neuropsychiatr Genet: Off Publ Int Soc Psychiatr Genet 141B:678–680

    Article  CAS  Google Scholar 

  • Salazar A, Gonzalez-Rivera BL, Redus L, Parrott JM, O’Connor JC (2012) Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge. Horm Behav 62:202–209

    Article  CAS  PubMed  Google Scholar 

  • Sanacora G, Treccani G, Popoli M (2012) Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 62:63–77

    Article  CAS  PubMed  Google Scholar 

  • Sasayama D, Hori H, Teraishi T, Hattori K, Ota M, Iijima Y, Tatsumi M, Higuchi T, Amano N, Kunugi H (2011) Possible association between interleukin-1beta gene and schizophrenia in a Japanese population. Behavioral Brain Funct: BBF 7:35

    Article  CAS  Google Scholar 

  • Sawada M, Itoh Y, Suzumura A, Marunouchi T (1993) Expression of cytokine receptors in cultured neuronal and glial cells. Neurosci Lett 160:131–134

    Article  CAS  PubMed  Google Scholar 

  • Schaefer M, Schwaiger M, Garkisch AS, Pich M, Hinzpeter A, Uebelhack R, Heinz A, van Boemmel F, Berg T (2005) Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C. J Hepatol 42:793–798

    Article  CAS  PubMed  Google Scholar 

  • Selten JP, Frissen A, Lensvelt-Mulders G, Morgan VA (2010) Schizophrenia and 1957 pandemic of influenza: meta-analysis. Schizophr Bull 36:219–228

    Article  PubMed  Google Scholar 

  • Shatz CJ (2009) MHC class I: an unexpected role in neuronal plasticity. Neuron 64:40–45

    Article  CAS  PubMed  Google Scholar 

  • Shi J et al (2009a) Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460:753–757

    CAS  PubMed  Google Scholar 

  • Shi L, Smith SE, Malkova N, Tse D, Su Y, Patterson PH (2009b) Activation of the maternal immune system alters cerebellar development in the offspring. Brain Behav Immun 23:116–123

    Article  PubMed  CAS  Google Scholar 

  • Silverman MN, Sternberg EM (2012) Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann N Y Acad Sci 1261:55–63

    Article  CAS  PubMed  Google Scholar 

  • Smith RS (1991) The macrophage theory of depression. Med Hypotheses 35:298–306

    Article  CAS  PubMed  Google Scholar 

  • Smith RS, Maes M (1995) The macrophage-T-lymphocyte theory of schizophrenia: additional evidence. Med Hypotheses 45:135–141

    Article  CAS  PubMed  Google Scholar 

  • Sommer IE, de Witte L, Begemann M, Kahn RS (2012) Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis. J Clin Psychiatry 73:414–419

    Article  CAS  PubMed  Google Scholar 

  • Song C, Wang H (2011) Cytokines mediated inflammation and decreased neurogenesis in animal models of depression. Prog Neuro-psychopharmacol & Biol Psychiatr 35:760–768

    Article  CAS  Google Scholar 

  • Stefansson H et al (2009) Common variants conferring risk of schizophrenia. Nature 460:744–747

    CAS  PubMed  Google Scholar 

  • Steiner J, Mawrin C, Ziegeler A, Bielau H, Ullrich O, Bernstein HG, Bogerts B (2006) Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization. Acta Neuropathol 112:305–316

    Article  CAS  PubMed  Google Scholar 

  • Steiner J, Bielau H, Brisch R, Danos P, Ullrich O, Mawrin C, Bernstein HG, Bogerts B (2008) Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res 42:151–157

    Article  PubMed  Google Scholar 

  • Steptoe A, Kunz-Ebrecht SR, Owen N (2003) Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women. Psychol Med 33:667–674

    Article  CAS  PubMed  Google Scholar 

  • Steptoe A, Wikman A, Molloy GJ, Messerli-Burgy N, Kaski JC (2012) Inflammation and symptoms of depression and anxiety in patients with acute coronary heart disease. Brain Behav Immun. doi:10.1016/j.bbi.2012.09.002

  • Stewart B, Mikocka-Walus A, Morgan J, Colman A, Phelps M, Harley H, Andrews J (2012) Anxiety and depression in Australian chronic hepatitis C outpatients: prevalence and predictors. Australasian Psychiatry: Bull R Aust N Z Coll Psychiatrists 20(6)496–500

    Google Scholar 

  • Stolp HB (2013) Neuropoietic cytokines in normal brain development and neurodevelopmental disorders. Mol Cell Neurosci 53:63–68

    Google Scholar 

  • Stone TW, Darlington LG (2002) Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov 1:609–620

    Article  CAS  PubMed  Google Scholar 

  • Sutcigil L, Oktenli C, Musabak U, Bozkurt A, Cansever A, Uzun O, Sanisoglu SY, Yesilova Z, Ozmenler N, Ozsahin A, Sengul A (2007) Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Clin Dev Immunol 2007:76396

    Article  PubMed  Google Scholar 

  • Suvisaari J, Haukka J, Tanskanen A, Hovi T, Lonnqvist J (1999) Association between prenatal exposure to poliovirus infection and adult schizophrenia. Am J Psychiatry 156:1100–1102

    CAS  PubMed  Google Scholar 

  • Sweeten TL, Posey DJ, McDougle CJ (2003) High blood monocyte counts and neopterin levels in children with autistic disorder. Am J Psychiatry 160:1691–1693

    Article  PubMed  Google Scholar 

  • Takei N, Mortensen PB, Klaening U, Murray RM, Sham PC, O’Callaghan E, Munk-Jorgensen P (1996) Relationship between in utero exposure to influenza epidemics and risk of schizophrenia in Denmark. Biol Psychiatry 40:817–824

    Article  CAS  PubMed  Google Scholar 

  • Tatsumi M, Sasaki T, Sakai T, Kamijima K, Fukuda R, Kunugi H, Hattori M, Nanko S (1997) Genes for interleukin-2 receptor beta chain, interleukin-1 beta, and schizophrenia: no evidence for the association or linkage. Am J Med Genet 74:338–341

    Article  CAS  PubMed  Google Scholar 

  • Tetreault NA, Hakeem AY, Jiang S, Williams BA, Allman E, Wold BJ, Allman JM (2012) Microglia in the cerebral cortex in autism. J Autism Dev Disord 42:2569–2584

    Article  PubMed  Google Scholar 

  • Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E (2003) Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology 170:429–433

    Article  CAS  PubMed  Google Scholar 

  • Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, Lalla D, Woolley M, Jahreis A, Zitnik R, Cella D, Krishnan R (2006) Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 367:29–35

    Article  CAS  PubMed  Google Scholar 

  • Udina M, Castellvi P, Moreno-Espana J, Navines R, Valdes M, Forns X, Langohr K, Sola R, Vieta E, Martin-Santos R (2012) Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis. J Clin Psychiatry 73:1128–1138

    Article  CAS  PubMed  Google Scholar 

  • van Dartel SA, Fransen J, Kievit W, Flendrie M, den Broeder AA, Visser H, Hartkamp A, van de Laar MA, van Riel PL (2012) Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry. Annals Rheum Dis. doi:10.1136/annrheumdis-2012-201338

  • van Os J, Kapur S (2009) Schizophrenia. Lancet 374:635–645

    Article  PubMed  CAS  Google Scholar 

  • Van Winkel R, Esquivel G, Kenis G, Wichers M, Collip D, Peerbooms O, Rutten B, Myin-Germeys I, Van Os J (2010) REVIEW: Genome-wide findings in schizophrenia and the role of gene-environment interplay. CNS Neurosci Ther 16:e185–e192

    Article  PubMed  CAS  Google Scholar 

  • Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA (2005) Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57:67–81

    Article  CAS  PubMed  Google Scholar 

  • Vignali DA, Collison LW, Workman CJ (2008) How regulatory T cells work. Nat Rev Immunol 8:523–532

    Article  CAS  PubMed  Google Scholar 

  • Vignau J, Costisella O, Canva V, Imbenotte M, Duhamel A, Lhermitte M (2009) Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients. L’Encéphale 35:477–483

    Article  CAS  PubMed  Google Scholar 

  • Vilar-Pereira G, Silva AA, Pereira IR, Silva RR, Moreira OC, de Almeida LR, de Souza AS, Rocha MS, Lannes-Vieira J (2012) Trypanosoma cruzi-induced depressive-like behavior is independent of meningoencephalitis but responsive to parasiticide and TNF-targeted therapeutic interventions. Brain Behav Immun 26:1136–1149

    Article  CAS  PubMed  Google Scholar 

  • Vitkovic L, Bockaert J, Jacque C (2000) “Inflammatory” cytokines: neuromodulators in normal brain? J Neurochem 74:457–471

    Article  CAS  PubMed  Google Scholar 

  • Vonk R, van der Schot AC, Kahn RS, Nolen WA, Drexhage HA (2007) Is autoimmune thyroiditis part of the genetic vulnerability (or an endophenotype) for bipolar disorder? Biol Psychiatry 62:135–140

    Article  CAS  PubMed  Google Scholar 

  • Vorhees CV, Graham DL, Braun AA, Schaefer TL, Skelton MR, Richtand NM, Williams MT (2012) Prenatal immune challenge in rats: altered responses to dopaminergic and glutamatergic agents, prepulse inhibition of acoustic startle, and reduced route-based learning as a function of maternal body weight gain after prenatal exposure to poly IC. Synapse 66:725–737

    Article  CAS  PubMed  Google Scholar 

  • Vuillermot S, Feldon J, Meyer U (2011) Nurr1 is not essential for the development of prepulse inhibition deficits induced by prenatal immune activation. Brain Behav Immun 25:1316–1321

    Article  CAS  PubMed  Google Scholar 

  • Wake H, Moorhouse AJ, Nabekura J (2011) Functions of microglia in the central nervous system–beyond the immune response. Neuron Glia Biol 7:47–53

    Article  PubMed  Google Scholar 

  • Walker FR (2013) A critical review of the mechanism of action for the selective serotonin reuptake inhibitors: do these drugs possess anti-inflammatory properties and how relevant is this in the treatment of depression? Neuropharmacology 67:304–317

    Article  CAS  PubMed  Google Scholar 

  • Warner-Schmidt JL, Vanover KE, Chen EY, Marshall JJ, Greengard P (2011) Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Proc Natl Acad Sci U S A 108:9262–9267

    Article  CAS  PubMed  Google Scholar 

  • Weigelt K, Carvalho LA, Drexhage RC, Wijkhuijs A, de Wit H, van Beveren NJ, Birkenhager TK, Bergink V, Drexhage HA (2011) TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors. Brain Behav Immun 25:1162–1169

    Article  CAS  PubMed  Google Scholar 

  • Wilson CJ, Finch CE, Cohen HJ (2002) Cytokines and cognition–the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc 50:2041–2056

    Article  PubMed  Google Scholar 

  • Winter C, Reutiman TJ, Folsom TD, Sohr R, Wolf RJ, Juckel G, Fatemi SH (2008) Dopamine and serotonin levels following prenatal viral infection in mouse–implications for psychiatric disorders such as schizophrenia and autism. Eur Neuropsychopharmacol: J Eur Coll Neuropsychopharmacol 18:712–716

    Article  CAS  Google Scholar 

  • Wolff AR, Cheyne KR, Bilkey DK (2011) Behavioural deficits associated with maternal immune activation in the rat model of schizophrenia. Behav Brain Re 225:382–387

    Article  Google Scholar 

  • Yang J, Si T, Ling Y, Ruan Y, Han Y, Wang X, Zhou M, Zhang D, Zhang H, Kong Q, Liu C, Li X, Yu Y, Liu S, Shu L, Ma D, Wei J, Zhang D (2003) Association study between interleukin-1beta gene (IL-1beta) and schizophrenia. Life Sci 72:3017–3021

    Article  CAS  PubMed  Google Scholar 

  • Yee N, Schwarting RK, Fuchs E, Wohr M (2012) Increased affective ultrasonic communication during fear learning in adult male rats exposed to maternal immune activation. J Psychiatr Res 46:1199–1205

    Article  PubMed  Google Scholar 

  • Yirmiya R (1996) Endotoxin produces a depressive-like episode in rats. Brain Res 711:163–174

    Article  CAS  PubMed  Google Scholar 

  • Zanardini R, Bocchio-Chiavetto L, Scassellati C, Bonvicini C, Tura GB, Rossi G, Perez J, Gennarelli M (2003) Association between IL-1beta -511C/T and IL-1RA (86bp)n repeats polymorphisms and schizophrenia. J Psychiatr Res 37:457–462

    Article  PubMed  Google Scholar 

  • Zaretsky MV, Alexander JM, Byrd W, Bawdon RE (2004) Transfer of inflammatory cytokines across the placenta. Obstet Gynecol 103:546–550

    Article  CAS  PubMed  Google Scholar 

  • Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Shen YC (2004) Changes in serum interleukin-2, -6, and −8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia. J Clin Psychiatry 65:940–947

    Article  CAS  PubMed  Google Scholar 

  • Zhang XY, Zhou DF, Qi LY, Chen S, Cao LY, da Chen C, Xiu MH, Wang F, Wu GY, Lu L, Kosten TA, Kosten TR (2009) Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics. Psychopharmacology 204:177–184

    Article  CAS  PubMed  Google Scholar 

  • Ziats MN, Rennert OM (2011) Expression profiling of autism candidate genes during human brain development implicates central immune signaling pathways. PLoS One 6:e24691

    Article  CAS  PubMed  Google Scholar 

  • Zimmerman AW, Jyonouchi H, Comi AM, Connors SL, Milstien S, Varsou A, Heyes MP (2005) Cerebrospinal fluid and serum markers of inflammation in autism. Pediatr Neurol 33:195–201

    Article  PubMed  Google Scholar 

  • Zorrilla EP, McKay JR, Luborsky L, Schmidt K (1996) Relation of stressors and depressive symptoms to clinical progression of viral illness. Am J Psychiatry 153:626–635

    CAS  PubMed  Google Scholar 

  • Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, McCorkle R, Seligman DA, Schmidt K (2001) The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 15:199–226

    Article  CAS  PubMed  Google Scholar 

  • Zunszain PA, Anacker C, Cattaneo A, Carvalho LA, Pariante CM (2011) Glucocorticoids, cytokines and brain abnormalities in depression. Prog Neuro-psychopharmacol Biol Psychiatry 35:722–729

    Article  CAS  Google Scholar 

Download references

Conflicts of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Immunology, Na1101, Erasmus MC, Dr. Molewaterplein 50, Erasmus MC, 3015 GE, Rotterdam, The Netherlands

    Sinead M. Gibney

  2. Department of Immunology, Dr. Molewaterplein 50, Erasmus MC, 3015 GE, Rotterdam, The Netherlands

    Hemmo A. Drexhage

Authors
  1. Sinead M. Gibney
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hemmo A. Drexhage
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sinead M. Gibney.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gibney, S.M., Drexhage, H.A. Evidence for a Dysregulated Immune System in the Etiology of Psychiatric Disorders. J Neuroimmune Pharmacol 8, 900–920 (2013). https://doi.org/10.1007/s11481-013-9462-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11481-013-9462-8

Keywords

Search

Navigation